Topoisomerase 1 activity during mitotic transcription favors the transition from mitosis to G1

Mol Cell. 2021 Dec 16;81(24):5007-5024.e9. doi: 10.1016/j.molcel.2021.10.015. Epub 2021 Nov 11.

Abstract

As cells enter mitosis, chromatin compacts to facilitate chromosome segregation yet remains transcribed. Transcription supercoils DNA to levels that can impede further progression of RNA polymerase II (RNAPII) unless it is removed by DNA topoisomerase 1 (TOP1). Using ChIP-seq on mitotic cells, we found that TOP1 is required for RNAPII translocation along genes. The stimulation of TOP1 activity by RNAPII during elongation allowed RNAPII clearance from genes in prometaphase and enabled chromosomal segregation. Disruption of the TOP1-RNAPII interaction impaired RNAPII spiking at promoters and triggered defects in the post-mitotic transcription program. This program includes factors necessary for cell growth, and cells with impaired TOP1-RNAPII interaction are more sensitive to inhibitors of mTOR signaling. We conclude that TOP1 is necessary for assisting transcription during mitosis with consequences for growth and gene expression long after mitosis is completed. In this sense, TOP1 ensures that cellular memory is preserved in subsequent generations.

Keywords: ChIP-seq; RNAPII; TOP1; cell cycle; mitosis; polymerase; segregation; supercoiling; topoisomerase; transcription.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Proliferation* / drug effects
  • Chromatin Assembly and Disassembly*
  • Chromatin Immunoprecipitation Sequencing
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / enzymology*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology
  • DNA Topoisomerases, Type I / genetics
  • DNA Topoisomerases, Type I / metabolism*
  • G1 Phase* / drug effects
  • Gene Expression Regulation, Neoplastic
  • HCT116 Cells
  • Humans
  • MTOR Inhibitors / pharmacology
  • Mitosis* / drug effects
  • RNA Polymerase II / genetics
  • RNA Polymerase II / metabolism*
  • Transcription, Genetic*

Substances

  • MTOR Inhibitors
  • RNA Polymerase II
  • DNA Topoisomerases, Type I
  • TOP1 protein, human